Evidence map›Paper›PMID 25884736›Full record

ArticleMalaria journal2015

Determinants of malaria diagnostic uptake in the retail sector: qualitative analysis from focus groups in Uganda.

Jessica Cohen, Alex Cox, William Dickens, Kathleen Maloney, Felix Lam, Günther Fink

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Jessica CohenDepartment of Global Health and Population, Harvard School of Public Health, Boston, MA, USA. cohenj@hsph.harvard.edu.
Alex CoxDepartment of Global Health and Population, Harvard School of Public Health, Boston, MA, USA. acox@mail.harvard.edu.
William DickensDepartment of Economics, Northeastern University, Boston, MA, USA. w.dickens@neu.edu.
Kathleen MaloneyMalaria Control Team, Clinton Health Access Initiative, Boston, MA, USA. kmaloney@clintonhealthaccess.org.
Felix LamEssential Medicines Team, Clinton Health Access Initiative, Boston, MA, USA. flam@clintonhealthaccess.org.
Günther FinkDepartment of Global Health and Population, Harvard School of Public Health, Boston, MA, USA. gfink@hsph.harvard.edu.
Boston University · USClinton Health Access Initiative · USHarvard Global Health Institute · USNortheastern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Uganda, as in most other malaria-endemic countries, presumptive treatment for malaria based on symptoms without a diagnostic blood test is still very common. While diagnostic testing in public sector facilities is increasing, many people in Uganda who suspect malaria visit private sector outlets to purchase medications. Increasing the availability and uptake of rapid diagnostic tests (RDTs) for malaria in private outlets could help increase diagnostic testing for malaria but raises questions about the patient demand for and valuation of testing that are less critical for public sector introduction.

methodsIn preparation for a behaviour change campaign to encourage and sustain the demand for RDTs in drug shops, eight focus group discussions with a total of 84 community members were conducted in six districts across Uganda's Eastern Region in November-December 2011. Focus groups explored incentives and barriers to seeking diagnosis for malaria, how people react to test results and why, and what can be done to increase the willingness to pay for RDTs.

resultsOverall, participants were very familiar with malaria diagnostic testing and understood its importance, yet when faced with limited financial resources, patients preferred to spend their money on medication and sought testing only when presumptive treatment proved ineffective. While side effects did seem to be a concern, participants did not mention other potential costs of taking unnecessary or ineffective medications, such as money wasted on excess drugs or delays in resolution of symptoms. Very few individuals were familiar with RDTs.

conclusionIn order to boost demand, these results suggest that private sector RDTs will have to be made convenient and affordable and that targeted behaviour change campaigns should strive to increase the perceived value of diagnosis.

Indexed as

AdultFemaleFocus GroupsHealth Knowledge, Attitudes, PracticeHumansMalariaMaleMiddle AgedPatient Acceptance of Health CarePublic SectorReagent Kits, DiagnosticUgandaReagent Kits, Diagnostic

Identifiers

PMID25884736
PMCPMC4338828
OpenAlexW2104335710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.